http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63215700-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate | 1987-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2896afa6f616fbcb47ef3111ec0293bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0a28d02ceb28f7a8af6cf93dfddc82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05660217b74e3b3b9448e67e0e28f684 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b57815339a29fca0639f29d6d755566d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b34d661fd9321f43ba7d22ebad0268 |
| publicationDate | 1988-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S63215700-A |
| titleOfInvention | Low-molecular weight protein |
| abstract | NEW MATERIAL:A compound having the sequence of 1W24 amino acids from the side of the amino terminal expressed by the formula and the following physico-chemical properties. Molecular weight; 19,000±2,000 (measured by a gel filtration method using TSK gel G3000SW) and 16,000±2,000 [sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE)]. Isoelectric point; pH4.9±0.3. Ultraviolet absorption; Maximum value at 277nm and minimum value at 250nm. Aqueous solution; Weak acidic. Color reaction; Capable of assuming color reaction of peptide bonds and amino acids to the biuret reaction, Folin-Lowry reaction method and ninhydrin reaction after hydrolysis. n USE: An antitumor agent. n PREPARATION: For example, a human-derived cultivated and established lymphatic cell is added to a culture medium and an antitumor substance inducer is added to carry out cultivation. The resultant supernatant liquid is collected by centrifugation, subjected to ion exchange chromatography, ultrafiltered and concentrated and then subjected to gel filtration to afford the aimed low- molecular weight protein having antitumor activity. n COPYRIGHT: (C)1988,JPO&Japio |
| priorityDate | 1987-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.